AKT3 OVEREXPRESSION Detail (hg38) (AKT3)

Information

Genome

Assembly Position
hg19 chr1:243,651,535-244,014,381 View the variant detail on this assembly version.
hg38 chr1:243,488,233-243,851,079
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM
HGNC
Ensembl
NCBI
Gene Cards
OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
breast cancer Akt Inhibitor MK2206 D Predictive Supports Resistance N/A 4 27297869 Detail
triple-receptor negative breast cancer Pan-AKT Kinase Inhibitor GSK690693 E Predictive Supports Sensitivity/Response N/A 4 24335962 Detail
melanoma Vemurafenib D Predictive Supports Resistance Somatic 2 24265155 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
Upregulation of AKT3 due to epigenetic reprogramming may confer acquired resistance to AKT inhibitor... CIViC Evidence Detail
AKT3 was found to be preferentially required for the proliferation and tumor growth of TNBC. It was ... CIViC Evidence Detail
An in vitro study of M229 (a human melanoma cell line) endogenously expressing wildtype AKT3 and BRA... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg38
Position
chr1:243,488,233-243,851,079
Variant Type
cnv
Variant (CIViC) (CIViC Variant)
OVEREXPRESSION
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1301
Genome browser